Financial Shenanigans

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The Forensic Verdict

Topicus screens as Watch (risk score 34/100). The operating engine — recurring-maintenance revenue, negative working capital, high deferred-revenue coverage, low capex — is faithfully represented in the cash-flow statement. The forensic risk is not in how revenue or operating income is reported. It is concentrated in three places: (1) the FY2025 Asseco Poland transaction, which dumped $260.5M of non-cash revaluation losses and $140.6M of derivative/dilution gains into a single year and forced a mid-year recast of Q1 2025 interim financials; (2) a structurally dense web of related-party arrangements with the controlling shareholder Constellation Software (CSI), the Joday Group, the Ijssel Group, Vela Software Group, and entities affiliated with the CEO and a key director; and (3) a non-controlling-interest structure where 35.8% of consolidated net income leaks to NCI before reaching subordinate voting shareholders. The single thing that would most change the grade is an audit-committee statement confirming KPMG had no scope or judgment disagreement on the Q1 2025 Asseco accounting treatment.

13-Shenanigan Scorecard

The pattern is clear: revenue, earnings, and cash flow from the operating business are clean. The forensic risk lives in non-operating line items — the Asseco transaction, the related-party constellation, and the structural cleavage between consolidated net income and net income attributable to subordinate voting shareholders.

Breeding Ground

The governance and incentive structure is a mixed bag — strong on equity-alignment hygiene, but heavy on control concentration and related-party density. Topicus is effectively controlled by Constellation Software Inc. (CSI) via a 10-vote multi-voting share class and the Joday Group's 29.4% non-controlling interest stake in Topicus Coop, which is exchangeable into subordinate voting shares. Three of eight directors (Mark Leonard, Robin van Poelje, Jamal Baksh) are non-independent; the CFO is not even paid by Topicus. KPMG LLP is up for re-appointment at the May 15, 2026 AGM and has audited the company since the 2020 spin-out — relatively short tenure for a Big Four engagement, with no qualification, emphasis paragraph, or material weakness on file.

The breeding-ground profile resembles CSI's: founder-anchored, equity-aligned, anti-promotional, audited by a Big Four firm, but with a tightly held control block and an audit committee that must scrutinize CSI-side transactions without a CFO who reports financially into Topicus. None of these are individually fatal — they are exactly the conditions that demand the forensic checks below.

Earnings Quality

Headline earnings are noisy. Reported FY2025 GAAP net income to Topicus shareholders was $49.1M, down 55% from FY2024's $108.1M — yet operating income rose 13% to $274.5M. The bridge from operating income to net income is dominated by a single non-operating item: a $260.5M revaluation loss recorded in Q3 2025 when Topicus elected to measure its Asseco Poland investment at cost under the equity method rather than at fair value through OCI. That charge offsets $140.6M of earlier-period derivative and dilution gains, plus $38.5M of FVTPL gains taken into earnings, plus $223.9M of fair-value movements that ran through OCI. The operating business kept compounding throughout — the noise is entirely below operating income.

Operating margins have stayed in a 12–18% band for seven straight years (FY2025: 15.0%) with maintenance-and-recurring revenue rising to 70.7% of total — that's the real earnings engine. The FY2021 net-income collapse to -$2.13B reflects spin-out share-based compensation accounting, not operating deterioration; this is well-documented in the inception prospectus and is an expected artifact of the Topicus Coop exchangeable-unit structure, not earnings management.

Receivables grew 22.0% in FY2025 against 19.9% revenue growth — a 2.1 percentage-point gap that is not a red flag at this scale, particularly when DSO actually improved from 51.7 to 49.1 days. Compare this to FY2019 where receivables outran revenue by 38 points: that was the early acquisition-driven scale-up, and unwound by FY2024. The trend is benign.

Deferred revenue grew 25% in FY2025 versus 20% revenue growth and added $42.2M from acquisitions — supporting the maintenance-prepayment narrative rather than overstated revenue recognition. Contracted-not-yet-recognized backlog of $1.53B at year-end (59% expected within 12 months) gives the FY26 revenue starting line strong visibility. Capitalized commission costs are a trivial $0.4M — Topicus is not propping margins via deferred sales-cost capitalization.

Cash Flow Quality

Operating cash flow conversion is real, not cosmetic. Adjusted for the $260.5M non-cash revaluation, the underlying CFO build comes from depreciation/amortization ($240M, all non-cash), prepaid maintenance contracts, and a $47.5M increase in deferred revenue. There is no factoring, no securitization, no supplier finance disclosed, and capitalized commissions are nil-material. The headline weakness is downstream: once acquisitions are subtracted, free cash flow available to deploy is roughly half of headline CFO, and once the $485M Asseco capital outlay is included, FY2025 generated negative invested-capital free cash flow.

CFO/NI is structurally inflated for two real (non-shenanigan) reasons: (1) intangibles amortization runs around $191M annually with no cash counterpart, and (2) the spin-out structure pumped non-cash share-based items through FY2021 net income. Ignoring those structural items, the operating business converts roughly 60–70% of EBITDA into operating cash — credible for VMS.

The CF build in FY2025 reveals the genuine story: $82M of GAAP net income + $240M of non-cash D&A + $261M of Asseco revaluation add-back + $33M working-capital benefit ≈ $484.9M of reported CFO. The working-capital lift is modest (7% of CFO) and is dominated by deferred-revenue inflows on prepaid maintenance — exactly what you'd expect from a 70%-recurring VMS business. DPO did stretch from 102 days to 113 days, contributing some payable-driven lift, but the dollar magnitude is small ($24M order of magnitude).

The compounder math: Topicus generates $485M of CFO but spends $332M on acquisitions, leaving $140M of true discretionary cash flow before the $485M Asseco outlay. Add the Asseco position and FY2025 was a -$345M cash-deficit year financed by a $520M increase in debt. Headline CFO/NI ratios will keep flattering this company until acquisitions slow. This is not a shenanigan — but it does mean that comparing TOI's $485M of FY25 CFO to peers' free cash flow without adjusting for the acquisition-spend run-rate misreads the durable capital return.

Metric Hygiene

Topicus's only repeated non-IFRS measure is Free Cash Flow Available to Shareholders ("FCFA2S"), defined in writing and reconciled line-by-line each quarter. The definition has not changed since the 2020 spin, and the reconciliation rigor exceeds most acquisitive software peers. The yellow flag is organic growth — the 4% figure cited as the FY2025 like-for-like growth rate uses estimated pre-acquisition revenues obtained from unaudited vendor financial information, with the company explicitly noting variances may be revised in subsequent quarters.

The two metrics worth a careful reader's attention are not on Topicus's metric page — they are buried in note disclosure. First, basic vs diluted share counts: at 83.3M basic shares the FY25 GAAP EPS is $0.59 but the 129.8M fully-diluted denominator (which includes exchangeable Coop units held by Joday, Ijssel, and CSI) is the economically correct base. Sell-side EPS using basic counts overstates the per-share economics by 56%. Second, NCI leakage: 35.8% of FY25 consolidated net income ($33.3M of $82.3M) accrues to non-controlling interests in Topicus Coop and individual operating-group subsidiaries (Sygnity 27.32% NCI, GeoSoftware and Geoactive each 40% NCI to Vela). Investors who model on consolidated net income systematically over-estimate the cash flow available to subordinate voting shareholders.

What to Underwrite Next

Five items to monitor in the FY2026 interim filings and the next annual report.

1. The Q1 2025 comparative recast. The MD&A states the Company "will recast the comparative interim period in its future filings in 2026" for the $36.9M net-income adjustment tied to Asseco accounting reclassification. Confirm the recast appears in Q1 2026 reporting without further revisions. If the recast widens beyond $36.9M, treat as a yellow flag escalation.

2. Asseco contribution under the equity method. With the 23.14% Asseco position now equity-method-accounted, expect 12 months of "share of net income (loss) of equity investees" to begin showing in Topicus's income statement. The transparency of which segment captures Asseco's contribution and whether it is broken out separately is the test. If Asseco's results are bundled into a generic "share in equity investees" line without disaggregation, that becomes a yellow flag.

3. Provisional purchase-price allocations. FY2025 acquisitions of $395.5M included provisional PPAs that "may differ from final PPAs and these differences may be material." Watch FY2026 disclosure for measurement-period adjustments to opening intangibles, deferred revenue, or contingent consideration. An adjustment exceeding 10% of provisional goodwill/intangibles would re-grade purchase accounting risk.

4. Related-party scope creep. Track three lines: (a) management fees to CSI ($3.5M FY25), (b) revenue from CSI affiliates ($12.2M FY25, up from $9.0M), (c) hosting/lease payments to CEO- and director-affiliated companies ($5.6M aggregate FY25). Any line exceeding 1% of total revenue or any new counterparty category warrants underwriting.

5. KPMG continuation. Re-appointment is a routine 2026 AGM item; non-continuation or new emphasis-of-matter language in the FY2026 audit report would materially re-grade the file.

The bottom line for position sizing: this is not a thesis-breaker. It is a forensic file that warrants a modest valuation discount versus pure-play SaaS peers — perhaps 1–2 turns of EV/EBITDA — and a discipline of valuing the business on net income attributable to subordinate voting shareholders and on fully diluted share counts. Investors who ignore the NCI leakage and the diluted share count will over-pay. Investors who understand them are looking at a faithfully-reported acquisitive compounder with one noisy non-operating year and a control structure they need to accept.